In silico Identification of Hypoxic Signature followed by reverse transcription-quantitative PCR Validation in Cancer Cell Lines
Iranian Biomedical Journal · 2023
DOI: 10.52547/ibj.3803 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iranian Biomedical Journal, 2023. Verfasst von Sara Shayan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Virology, Pasteur Institute of Iran, Tehran, Iran. Hauptthemen laut MEDLINE: MicroRNAs, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Virology, Pasteur Institute of Iran, Tehran, Iran.
- Department of Hepatitis and AIDS and Blood Borne Diseases, Pasteur Institute of Iran, Tehran, Iran.
Zitieren
APA
Shayan, S., Bahramali, G., Arashkia, A., & Azadmanesh, K. (2023). In silico Identification of Hypoxic Signature followed by reverse transcription-quantitative PCR Validation in Cancer Cell Lines. Iranian Biomedical Journal. https://doi.org/10.52547/ibj.3803
Vancouver
Shayan S, Bahramali G, Arashkia A, Azadmanesh K. In silico Identification of Hypoxic Signature followed by reverse transcription-quantitative PCR Validation in Cancer Cell Lines. Iranian Biomedical Journal. 2023. doi:10.52547/ibj.3803
BibTeX
@article{Shayan2023,
author = {Shayan, Sara and Bahramali, Golnaz and Arashkia, Arash and Azadmanesh, Kayhan},
title = {In silico Identification of Hypoxic Signature followed by reverse transcription-quantitative PCR Validation in Cancer Cell Lines},
journal = {Iranian Biomedical Journal},
year = {2023},
doi = {10.52547/ibj.3803}
}
EUVIMED